| Intrinsic Valuation of: CG | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 1 | Market Cap | $17B | |||||
| 2021 | - | - (-) | P/E Ratio | 33 | Total Asset | $29B | |||||
| 2022 | $-1B | - (-) | Net Income | $809M | Total Debt | $0 | |||||
| 2023 | $138M | 113.3% (133.8%) | EBITDA | - | Total Liab | $22B | |||||
| 2024 | $-837M | -705.4% (-335.6%) | Opr Margin | - | Debt/Equity | - | |||||
| 2025 | $-3B | -303.1% (-326.9%) | PreTax Margin | - | BV/Share | 15 | |||||
| 5Y Average FCF | $-1B | 3.5% (-176.2%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 13.86% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (3.5%) | ||||||||||
| 2026 | $143M | MBG Intrinsic Value | $13 | ||||||||
| 2027 | $148M | ||||||||||
| 2028 | $152M | ||||||||||
| 2029 | $157M | ||||||||||
| 2030 | $161M | ||||||||||
| 2031 | $165M | ||||||||||
| Terminal Value | $1B | Net Worth/Share | $20 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $1B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $3B | $12 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $0 | WACC | 11.9% | 13 | 13 | 13 | 13 | 14 | |||
| Equity Value | $4B | 12.4% | 13 | 13 | 13 | 13 | 13 | ||||
| Shares Outstanding | 359,974,427 | 12.9% | 13 | 13 | 13 | 13 | 13 | ||||
| 13.5% | 12 | 12 | 13 | 13 | 13 | ||||||
| DCF Intrinsic Value | $12 | 14.0% | 12 | 12 | 12 | 13 | 13 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||